World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
61
Citations
15249
World Ranking
3217
National Ranking
78

Colin Kovacs publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Colin Kovacs sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 176 publications — 25th percentile

25% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Colin Kovacs D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Colin Kovacs sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 61 D-Index — 36th percentile

36% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Colin Kovacs is affiliated with the University of Toronto in Canada. Their research primarily spans the fields of Medicine and Immunology and Microbiology, with a focus on Infectious Diseases, Virology, Immunology, Epidemiology, and Obstetrics and Gynecology.

The scientist's work addresses a number of main topics, including:

  • HIV Research and Treatment
  • SARS-CoV-2 and COVID-19 Research
  • HIV/AIDS drug development and treatment
  • HIV/AIDS Research and Interventions
  • Immune Cell Function and Interaction
  • COVID-19 Impact on Reproduction
  • Vaccine Coverage and Hesitancy

Colin Kovacs has published extensively in several research venues, with frequent contributions to:

  • Journal of Virology
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Journal of Clinical Investigation
  • AIDS
  • Nature Communications

Recent papers associated with Colin Kovacs include:

  • "BCL-2 antagonism sensitizes cytotoxic T cell-resistant HIV reservoirs to elimination ex vivo" (2020, Journal of Clinical Investigation)
  • "HIV-1 diversity considerations in the application of the Intact Proviral DNA Assay (IPDA)" (2021, Nature Communications)
  • "The latent reservoir of inducible, infectious HIV-1 does not decrease despite decades of antiretroviral therapy" (2023, Journal of Clinical Investigation)
  • "COVID-19 vaccine immunogenicity in people with HIV" (2022, AIDS)
  • "Asymptomatic neurocognitive impairment is a risk for symptomatic decline over a 3-year study period" (2020, AIDS)

Frequent co-authors of Colin Kovacs include:

  • Erika Benko
  • R. Brad Jones
  • Mario Ostrowski
  • Yanqin Ren
  • Szu-Han Huang

Best Publications

  • Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells.

    Janet D Siliciano;Joleen Kajdas;Diana Finzi;Thomas C Quinn;Thomas C Quinn

  • Tim-3 expression defines a novel population of dysfunctional T cells with highly elevated frequencies in progressive HIV-1 infection

    R. Brad Jones;Lishomwa C Ndhlovu;Jason D. Barbour;Prameet M. Sheth

  • Characterization of CD56-/CD16+ natural killer (NK) cells: a highly dysfunctional NK subset expanded in HIV-infected viremic individuals.

    Domenico Mavilio;Gabriella Lombardo;Janet Benjamin;Diana Kim

  • Rapid and durable antiretroviral effect of the HIV-1 Integrase inhibitor raltegravir as part of combination therapy in treatment-naive patients with HIV-1 infection: results of a 48-week controlled study.

    Martin Markowitz;Bach-Yen Nguyen;Eduardo Gotuzzo;Fernando Mendo

  • Antiretroviral activity, pharmacokinetics, and tolerability of MK-0518, a novel inhibitor of HIV-1 integrase, dosed as monotherapy for 10 days in treatment-naive HIV-1-infected individuals.

    Martin Markowitz;Javier O Morales-Ramirez;Bach-Yen Nguyen;Colin M Kovacs

  • Perforin Expression Directly Ex Vivo by HIV-Specific CD8 + T-Cells Is a Correlate of HIV Elite Control

    Adam R. Hersperger;Florencia Pereyra;Martha Nason;Korey R. Demers

  • Defective HIV-1 Proviruses Are Expressed and Can Be Recognized by Cytotoxic T Lymphocytes, which Shape the Proviral Landscape.

    Ross A. Pollack;R. Brad Jones;Mihaela Pertea;Katherine M. Bruner

  • Effects of vitamin E and C supplementation on oxidative stress and viral load in HIV-infected subjects.

    Johane P. Allard;Elaheh Aghdassi;Jenny Chau;Carolyn Tam

  • HIV-infected individuals receiving effective antiviral therapy for extended periods of time continually replenish their viral reservoir

    Tae Wook Chun;David C. Nickle;J. Shawn Justement;Danielle Large

  • Rebound of plasma viremia following cessation of antiretroviral therapy despite profoundly low levels of HIV reservoir: implications for eradication.

    Tae Wook Chun;J. Shawn Justement;Danielle Murray;Claire W. Hallahan

  • Decreased survival of B cells of HIV-viremic patients mediated by altered expression of receptors of the TNF superfamily.

    Susan Moir;Angela Malaspina;Oxana K. Pickeral;Eileen T. Donoghue

  • Distinct Transcriptional Profiles in Ex Vivo CD4+ and CD8+ T Cells Are Established Early in Human Immunodeficiency Virus Type 1 Infection and Are Characterized by a Chronic Interferon Response as Well as Extensive Transcriptional Changes in CD8+ T Cells

    Martin D. Hyrcza;Colin Kovacs;Mona Loutfy;Roberta Halpenny

  • Histone Deacetylase Inhibitors Impair the Elimination of HIV-Infected Cells by Cytotoxic T-Lymphocytes

    Richard Brad Jones;Rachel O'Connor;Stefanie Mueller;Maria Hottelet Foley

  • A role for mucosal IL-22 production and Th22 cells in HIV-associated mucosal immunopathogenesis

    C J Kim;A Nazli;O L Rojas;D Chege

  • Increased HIV-specific CD8+ T-cell cytotoxic potential in HIV elite controllers is associated with T-bet expression.

    Adam R. Hersperger;Jeffrey N. Martin;Lucy Y. Shin;Prameet M. Sheth

  • Characterization of the defective interaction between a subset of natural killer cells and dendritic cells in HIV-1 infection

    Domenico Mavilio;Gabriella Lombardo;Audrey Kinter;Manuela Fogli

  • Relationship Between Residual Plasma Viremia and the Size of HIV Proviral DNA Reservoirs in Infected Individuals Receiving Effective Antiretroviral Therapy

    Tae-Wook Chun;Danielle Murray;J. Shawn Justement;Claire W. Hallahan

  • Latent HIV reservoirs exhibit inherent resistance to elimination by CD8+ T cells

    Szu Han Huang;Yanqin Ren;Allison S. Thomas;Dora Chan

  • CD25+ regulatory T cells isolated from HIV-infected individuals suppress the cytolytic and nonlytic antiviral activity of HIV-specific CD8+ T cells in vitro.

    Audrey L. Kinter;Robin Horak;Melanie Sion;Lindsey Riggin

  • A Subset of Latency-Reversing Agents Expose HIV-Infected Resting CD4+ T-Cells to Recognition by Cytotoxic T-Lymphocytes.

    R. Brad Jones;R. Brad Jones;Stefanie Mueller;Rachel O’Connor;Katherine Rimpel

  • Persistent HIV RNA shedding in semen despite effective antiretroviral therapy.

    Prameet M Sheth;Colin Kovacs;Kimdar S Kemal;R Brad Jones

Frequent Co-Authors

Mario A. Ostrowski
Mario A. Ostrowski University of Toronto
Rupert Kaul
Rupert Kaul University of Toronto
Bruce D. Walker
Bruce D. Walker Harvard University
Anthony S. Fauci
Anthony S. Fauci Georgetown University
Tae-Wook Chun
Tae-Wook Chun National Institute of Allergy and Infectious Diseases
Sharon Walmsley
Sharon Walmsley University Health Network
Susan Moir
Susan Moir National Institute of Allergy and Infectious Diseases
Zabrina L. Brumme
Zabrina L. Brumme Simon Fraser University
Jean-Pierre Routy
Jean-Pierre Routy McGill University Health Centre
Claire W. Hallahan
Claire W. Hallahan National Institute of Allergy and Infectious Diseases

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Immunology in the USA opens doors to various healthcare roles and advanced scientific careers. Many students consider online nursing degrees to complement their immunology knowledge, especially if transitioning into clinical roles. For those without a nursing background, exploring online adn programs for non nurses can provide an accessible pathway into nursing and healthcare practice.

Accelerated options are also popular among career changers or individuals seeking faster entry. Programs like the accelerated nursing programs near me allow students with prior degrees to earn a BSN quickly, bridging immunology expertise with nursing skills.

For those interested in more hands-on patient care, simple entry points include easy lpn programs to get into, which can lead to practical nursing roles within healthcare settings where immunology knowledge is valuable.

Furthermore, advancing to advanced practice roles is feasible through nursing education pathways. Identifying which nurse practitioner program is easiest can help students balance rigorous academics with career growth.

By combining immunology studies with these related online degrees, students can enhance their qualifications and explore diverse career pathways in healthcare and biomedical sciences.

Best Scientists Citing Colin Kovacs

Trending Scientists

Recently Published Articles